Vitamin D Deficiency Clinical Trial
Official title:
High-dose Vitamin D Supplementation Reduces Inflammation and Improves Microcirculation in Patients With Diabetic Peripheral Neuropathy
Aim. To assess the effect of different doses of vitamin D supplementation on peripheral
neuropathy in patients with type 2 diabetes mellitus (T2DM).
68 patients with T2DM and peripheral neuropathy will be randomized into two treatment groups:
cholecalciferol 5,000 IU once/week and cholecalciferol 40,000 IU once/week orally for 24
weeks. Severity of neuropathy (neuropathy symptom score (NSS), neuropathy disability score
(NDS), visual analog scale (VAS)), body mass index (BMI), glycated hemoglobin (HbA1c),
25-hydroxycalciferol (25(OH)D), parathyroid hormone (PTH), serum interleukins (IL) 1β, 6 and
10, C-reactive protein, tumor necrosis factor α and microcirculation (MC) parameters assessed
before and after treatment. The initial and final indicators of the skin blood flow (M, σ,
Kv) and MC parameters after postural and occlusal tests by laser Doppler flowmetry (LDF).
Sixteen subjects without diabetes will represent the control group.
It is well known that vitamin D deficiency along with type 2 diabetes mellitus (T2DM) is a
modern pandemic. Development of microvascular complications in T2DM worsens both the
prognosis and the patients' quality of life. There is increasing evidence of a possible
contribution of vitamin D deficiency to the pathogenesis of diabetes and its complications.
Large-scale studies have shown 40% increased risk of developing diabetes in individuals with
a reduced 25(OH)D level. A recent interventional prospective study demonstrated no decrease
in the risk of T2DM development in patients with prediabetes after two-year treatment with
4,000 IU of vitamin D per day. But, some experts suggested that 4,000 IU is not sufficient
supplementation dose for patients with already existing impaired glucose metabolism and on
the other hand most study participants had normal basal 25(OH)D level. Along with
immune-mediated mechanisms, microcirculation deterioration in patients with diabetes has been
found to play an important role in the pathogenesis of microvascular complications including
peripheral neuropathy (DPN).
It is believed that vitamin D deficiency also plays a role in the progression of DPN. Thus,
the correction of vitamin D deficiency in patients with T2DM is becoming increasingly
attractive for the prevention and treatment of microvascular complications. However, the
question of the required vitamin D dose and the treatment duration remain highly debatable.
The aim of this study was to assess the effect of therapy with different doses of
cholecalciferol for 24 weeks on clinical manifestations of peripheral neuropathy,
inflammatory markers, and parameters of microcirculation in patients with T2DM.
Patients and Methods: Baseline characteristics will be recorded for all patients including
Height, weight, BMI, diabetes status and biochemical parameters. All will be repeated at 24
weeks. Blood will be collected after an overnight fast and stored at -20 degrees until
analysis.
Patients will be recruited from the Almazov Research centre, St Petersburg, Russia
Federation.
68 patients with T2DM and peripheral neuropathy will be randomized into two treatment groups:
cholecalciferol 5,000 IU once/week and cholecalciferol 40,000 IU once/week orally for 24
weeks. Severity of neuropathy (neuropathy symptom score (NSS), neuropathy disability score
(NDS), visual analog scale (VAS)), body mass index (BMI), glycated hemoglobin (HbA1c),
25-hydroxycalciferol (25(OH)D), parathyroid hormone (PTH), serum interleukins (IL) 1β, 6 and
10, C-reactive protein, tumor necrosis factor α and microcirculation (MC) parameters assessed
before and after treatment. The initial and final indicators of the skin blood flow (M, σ,
Kv) and MC parameters after postural and occlusal tests by laser Doppler flowmetry (LDF).
Sixteen subjects without diabetes will represent the control group.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04244474 -
Effect of Vitamin D Supplementation on Improvement of Pneumonic Children
|
Phase 1/Phase 2 | |
Recruiting |
NCT05459298 -
ViDES Trial (Vitamin D Extra Supplementation)
|
N/A | |
Suspended |
NCT03652987 -
Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
|
||
Completed |
NCT04476511 -
The Efficacy and the Safety of Vitamin D3 30,000 IU for Loading Dose Schedules
|
Phase 3 | |
Completed |
NCT03920150 -
Vitamin D 24'000 IU for Oral Intermittent Supplementation
|
Phase 3 | |
Completed |
NCT03264625 -
The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis
|
Phase 2 | |
Completed |
NCT04183257 -
Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics
|
Phase 4 | |
Recruiting |
NCT05084248 -
Vitamin D Deficiency in Adults Following a Major Burn Injury
|
Phase 4 | |
Completed |
NCT05506696 -
Vitamin D Supplementation Study
|
N/A | |
Completed |
NCT00092066 -
A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)
|
Phase 3 | |
Completed |
NCT03234218 -
Vitamin D Levels in Liver Transplantation Recipients Prospective Observational Study
|
||
Completed |
NCT02906319 -
Vitamin D and HbA1c Levels in Diabetic Patients With CKD
|
N/A | |
Completed |
NCT03203382 -
Corneal Nerve Structure in Sjogren's
|
||
Completed |
NCT02714361 -
A Study to Investigate the Effect of Vitamin D3 Supplementation on Iron Status in Iron Deficient Women
|
N/A | |
Completed |
NCT02118129 -
Vitamin D Among Young Adults: an Intervention Study Using a Mobile 'App'.
|
N/A | |
Completed |
NCT02275650 -
The Role of Narrowband Ultraviolet B Exposure in the Maintenance of Vitamin D Levels During Winter
|
N/A | |
Not yet recruiting |
NCT01419821 -
Vitamin D and Its Affect on Growth Rates and Bone Mineral Density Until Age 5
|
N/A | |
Completed |
NCT02187146 -
The Effects of Serum Vitamin D and IVF Outcome
|
N/A | |
Completed |
NCT01688102 -
The Effect of Oral Vitamin D Versus Narrow-Band UV-B Exposure on the Lipid Profile
|
N/A | |
Completed |
NCT01741181 -
Vitamin D Supplementation in Patients With Diabetes Mellitus Type 2
|
Phase 4 |